Control of Major Bleeding After Trauma Study
Stopped early · Phase 2
Conditions studied: Trauma, Hemorrhagic Shock
In brief
Bleeding is the most avoidable cause of death in trauma patients. Up to one-third of severely injured trauma patients are found to be coagulopathic and forty percent of the mortality following severe injury is due to uncontrollable hemorrhage in the setting of coagulopathy. It has been established that early administration of fresh frozen plasma decreases mortality following severe injury, replacing lost coagulation factors, improving the coagulopathy and restoring blood volume. This study will determine if giving plasma to severely injured trauma patients during ambulance transport versus after arrival to the hospital will help reduce hemorrhage, thus decreasing both total blood product administration and mortality.
Key facts
- Study ID
- NCT01838863
- Run by
- Denver Health and Hospital Authority
- People needed
- 144
- Starts
- 2014-04-07
- Expected to finish
- 2017-04-03
- Last updated by the study team
- 2019-01-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age>=18 years
- Acutely injured
- SBP<70 mmHg or SBP 71-90 mmHg with heart rate (HR)>108 beats per minute.
You may not qualify if…
- Visibly or verbally reported pregnant women
- known prisoners
- unsalvageable injuries (defined as asystolic or cardiopulmonary resuscitation prior to randomization)
- known objection to blood products
- the patient has an opt-out bracelet or, necklace or wallet card
- a family member present at the scene objects to the patient's enrollment in research.
Where it is running
- Denver Health Medical Center — Denver, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.